John Libbey Eurotext

Troubles de l'apprentissage chez l'enfant épileptique : impact des médicaments Volume 3, numéro spécial 3, Numéro spécial 2, December 2001

1. Lennox W. Brain injury, drugs, and environment as causes of mental decay in epilepsy. Am J Psychiatry 1942 ; 99 : 174-80.

2. Yanai J, Fares F, Gavish M, et al. Neural and behavioral alterations after early exposure to phenobarbital. Neurotoxicology 1989 ; 10 : 543-54.

3. Bergman A, Roselli-Austin L, Yedwab G, Yanai J. Neuronal deficits in mice following phenobarbital exposure during various periods in fetal development. Acta Anat 1980 ; 108 : 370-3.

4. Middaugh LD, Simpson LW, Thomas TN, Zemp JW. Prenatal maternal phenobarbital increases reactivity and retards habituation of mature offspring to environmental stimuli. Psychopharmacology 1981 ; 74 : 349-52.

5. Fonseca NM, Sell AB, Carlini EA. Differential behavioral responses of male and female adult rats treated with five psychotropic drugs in the neonatal stage. Psychopharmacologia 1976 ; 46 : 263-8.

6. Pereira de Vasconcelos A, Schroeder H, Nehlig A. Effects of early chronic phenobarbital treatment on the maturation of energy metabolism in the developing rat brain. II. Incorporation of beta-hydroxybutyrate into amino acids. Brain Res 1987 ; 433 : 231-6.

7. Pereira de Vasconcelos A, Nehlig A. Effects of early chronic phenobarbital treatment on the maturation of energy metabolism in the developing rat brain. I. Incorporation of glucose carbon into amino acids. Brain Res 1987 ; 433 : 219-29.

8. Pereira de Vasconcelos A, Boyet S, Nehlig A. Consequences of chronic phenobarbital treatment on local cerebral glucose utilization in the developing rat. Brain Res Dev Brain Res 1990 ; 53 : 168-78.

9. Chesley S, Lumpkin M, Schatzki A, et al. Prenatal exposure to benzodiazepine-I. Prenatal exposure to lorazepam in mice alters open-field activity and GABAA receptor function. Neuropharmacology 1991 ; 30 : 53-8.

10. Tucker JC. Benzodiazepines and the developing rat : a critical review. Neurosci Biobehav Rev 1985 ; 9 : 101-11.

11. Kellogg CK, Simmons RD, Miller RK, Ison JR. Prenatal diazepam exposure in rats : long-lasting functional changes in the offspring. Neurobehav Toxicol Teratol 1985 ; 7 : 483-8.

12. Shapiro S, Hartz SC, Siskind V, et al. Anticonvulsants and parental epilepsy in the development of birth defects. Lancet 1976 ; 1 : 272-5.

13. Lindhout D, Omtzigt JG. Teratogenic effects of antiepileptic drugs : implications for the management of epilepsy in women of childbearing age. Epilepsia 1994 ; 35 : S19-28.

14. Omtzigt JG, Los FJ, Grobbee DE, et al. The risk of spina bifida aperta after first-trimester exposure to valproate in a prenatal cohort. Neurology 1992 ; 42 : 119-25.

15. Martinez-Frias ML. Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information. Am J Med Genet 1990 ; 37 : 277-82.

16. Hiilesmaa VK. Pregnancy and birth in women with epilepsy. Neurology 1992 ; 42 : 8-11.

17. Lewis DP, Van Dyke DC, Stumbo PJ, Berg MJ. Drug and environmental factors associated with adverse pregnancy outcomes. Part I : antiepileptic drugs, contraceptives, smoking, and folate. Ann Pharmacother 1998 ; 32 : 802-17.

18. Jones KL, Lacro RV, Johnson KA, Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 1989 ; 320 : 1661-6.

19. Dabee V, Hart AG, Hurley RM. Teratogenic effects of diphenylhydantoin. Can Med Assoc J 1975 ; 112 : 75-7.

20. Finnell RH, Abbott LC, Taylor SM. The fetal hydantoin syndrome : answers from a mouse model. Reprod Toxicol 1989 ; 3 : 127-33.

21. Buehler BA, Delimont D, van Waes M, Finnell RH. Prenatal prediction of risk of the fetal hydantoin syndrome. N Engl J Med 1990 ; 322 : 1567-72.

22. Samren EB, van Duijn CM, Christiaens GC, Hofman A, Lindhout D. Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 1999 ; 46 : 739-46.

23. Losche G, Steinhausen HC, Koch S, Helge H. The psychological development of children of epileptic parents. II. The differential impact of intrauterine exposure to anticonvulsant drugs and further influential factors. Acta Paediatr 1994 ; 83 : 961-6.

24. Koch S, Jager-Roman E, Losche G, Nau H, Rating D, Helge H. Antiepileptic drug treatment in pregnancy : drug side effects in the neonate and neurological outcome. Acta Paediatr 1996 ; 85 : 739-46.

25. van der Pol MC, Hadders-Algra M, Huisjes HJ, Touwen BC. Antiepileptic medication in pregnancy : late effects on the children's central nervous system development. Am J Obstet Gynecol 1991 ; 164 : 121-8.

26. Hiilesmaa VK, Teramo K, Granstrom ML, Bardy AH. Fetal head growth retardation associated with maternal antiepileptic drugs. Lancet 1981 ; 2 : 165-7.

27. Gaily EK, Granstrom ML, Hiilesmaa VK, Bardy AH. Head circumference in children of epileptic mothers : contributions of drug exposure and genetic background. Epilepsy Res 1990 ; 5 : 217-22.

28. Speidel BD, Meadow SR. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet 1972 ; 2 : 839-43.

29. Gaily E, Kantola-Sorsa E, Granstrom ML. Intelligence of children of epileptic mothers. J Pediatr 1988 ; 113 : 677-84.

30. Gaily E, Kantola-Sorsa E, Granstrom ML. Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol 1990 ; 32 : 403-14.

31. Scolnik D, Nulman I, Rovet J, et al. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA 1994 ; 271 : 767-70.

32. Dessens A, Cohen-Kettenis P, Mellenbergh G, van de Poll N, Koppe J, Boer K. Prenatal exposure to anticonvulsant drugs and spatial ability in adulthood. Acta Neurobiol Exp 1998 ; 58 : 221-5.

33. Dessens AB, Cohen-Kettenis PT, Mellenbergh GJ, van de Poll N, Koppe JG, Boer K. Prenatal exposure to anticonvulsants and psychosexual development. Arch Sex Behav 1999 ; 28 : 31-44.

34. Tholl DA, Miller TQ, Henderson WG, Myers TF. Meta-analysis of phenobarbital usage for prevention of intraventricular hemorrhage in premature infants : factors related to variation in outcome. Clin Trials Metaanal 1994 ; 29 : 177-90.

35. Bedard MP, Shankaran S, Slovis TL, Pantoja A, Dayal B, Poland RL. Effect of prophylactic phenobarbital on intraventricular hemorrhage in high-risk infants. Pediatrics 1984 ; 73 : 435-9.

36. Shankaran S, Papile LA, Wright LL, et al. The effect of antenatal phenobarbital therapy on neonatal intracranial hemorrhage in preterm infants. N Engl J Med 1997 ; 337 : 466-71.

37. Thorp JA, O'Connor M, Jones AM, Hoffman EL, Belden B. Does perinatal phenobarbital exposure affect developmental outcome at age 2 ? Am J Perinatol 1999 ; 16 : 51-60.

38. Shankaran S, Woldt E, Nelson J, Bedard M, Delaney-Black V. Antenatal phenobarbital therapy and neonatal outcome. II : Neurodevelopmental outcome at 36 months. Pediatrics 1996 ; 97 : 649-52.

39. Curran HV, Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 1993 ; 44 : 529-33.

40. Thompson P, Huppert FA, Trimble M. Phenytoin and cognitive function : effects on normal volunteers and implications for epilepsy. Br J Clin Psychol 1981 ; 20 : 155-62.

41. Thompson PJ, Trimble MR. Sodium valproate and cognitive functioning in normal volunteers. Br J Clin Pharmacol 1981 ; 12 : 819-24.

42. Boxer CM, Herzberg JL, Scott DF. Has sodium valproate hypnotic effects ? Epilepsia 1976 ; 17 : 367-70.

43. Akaho R. The effects of antiepileptic drugs on cognition in normal volunteers. Psychiatry Clin Neurosci 1996 ; 50 : 61-9.

44. Curran H. Benzodiazepines, memory and mood : a review. Psychopharmacology 1991 ; 105 : 1-8.

45. Vidailhet P, Danion JM, Kauffmann-Muller F, et al. Lorazepam and diazepam effects on memory acquisition in priming tasks. Psychopharmacology (Berl) 1994 ; 115 : 397-406.

46. Ghoneim MM, Hinrichs JV, Mewaldt SP. Dose-response analysis of the behavioral effects of diazepam : I. Learning and memory. Psychopharmacology 1984 ; 82 : 291-5.

47. Pompeia S, Gorenstein C, Curran HV. Benzodiazepine effects on memory tests : dependence on retrieval cues ? Int Clin Psychopharmacol 1996 ; 11 : 229-36.

48. Bishop KC, HV. Psychopharmacological analysis of implicit and explicit memory : a study with lorazepam and the benzodiazepine antagonist flumazenil. Psychopharmacology 1995 ; 121 : 267-78.

49. Duncan JS, Shorvon SD, Trimble MR. Effects of removal of phenytoin, carbamazepine, and valproate on cognitive function. Epilepsia 1990 ; 31 : 584-91.

50. Prevey ML, Mattson RH, Cramer JA. Improvement in cognitive functioning and mood state after conversion to valproate monotherapy. Neurology 1989 ; 39 : 1640-1.

51. Loiseau P, Strube E, Broustet D, Battellochi S, Gomeni C, Morselli PL. Learning impairment in epileptic patients. Epilepsia 1983 ; 24 : 183-92.

52. Devinsky O. Cognitive and behavioral effects of antiepileptic drugs. Epilepsia 1995 ; 36 : S46-65.

53. Bourgeois BF. Antiepileptic drugs, learning, and behavior in childhood epilepsy. Epilepsia 1998 ; 39 : 913-21.

54. Billard C. Anti-epileptic drugs and cognitive function. In : Nehlig A, Motte J, Solomon ML, Plouin P, eds. Childhood epilepsies and brain development. London : John Libbey and Co, 1999 : 279-88.

55. Dodrill CB, Troupin AS. Psychotropic effects of carbamazepine in epilepsy : a double-blind comparison with phenytoin. Neurology 1977 ; 27 : 1023-8.

56. Dodrill CB, Troupin AS. Neuropsychological effects of carbamazepine and phenytoin : a reanalysis. Neurology 1991 ; 41 : 141-3.

57. Farwell JR, Lee YJ, Hirtz DG, Sulzbacher SI, Ellenberg JH, Nelson KB. Phenobarbital for febrile seizures-effects on intelligence and on seizure recurrence. N Engl J Med 1990 ; 322 : 364-9.

58. Aldenkamp AP, Alpherts WC, Blennow G, et al. Withdrawal of antiepileptic medication in children-effects on cognitive function : the Multicenter holmfrid study. Neurology 1993 ; 43 : 41-50.

59. Marciani MG, Stanzione P, Mattia D, et al. Lamotrigine add-on therapy in focal epilepsy : electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol 1998 ; 21 : 41-7.

60. Meador KJ, Baker GA. Behavioral and cognitive effects of lamotrigine. J Child Neurol 1997 ; 12 (suppl 1) : S44-7.

61. Bouman WP, Pinner G, Johnson H. Cognitive impairment associated with lamotrigine [letter]. Br J Psychiatry 1997 ; 170 : 388-9.

62. Banks GK, Beran RG. Neuropsychological assessment in lamotrigine treated epileptic patients. Clin Exp Neurol 1991 ; 28 : 230-7.

63. Khan A, Faught E, Gilliam F, Kuzniecky R. Acute psychotic symptoms induced by topiramate. Seizure 1999 ; 8 : 235-7.

64. Mohamed K, Appleton R, Rosenbloom L. Efficacy and tolerability of topiramate in childhood and adolescent epilepsy : a clinical experience. Seizure 2000 ; 9 : 137-41.

65. Gerber PE, Hamiwka L, Connolly MB, Farrell K. Factors associated with behavioral and cognitive abnormalities in children receiving topiramate. Pediatr Neurol 2000 ; 22 : 200-3.

66. Mortimore C, Trimble M, Emmers E. Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure 1998 ; 7 : 359-64.

67. Dodrill CB, Arnett JL, Hayes AG, et al. Cognitive abilities and adjustment with gabapentin : results of a multisite study. Epilepsy Res 1999 ; 35 : 109-21.

68. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999 ; 40 : 1279-85.

69. Leach JP, Girvan J, Paul A, Brodie MJ. Gabapentin and cognition : a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997 ; 62 : 372-6.

70. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999 ; 52 : 321-7.

71. Jambaque I, Chiron C, Dumas C, Mumford J, Dulac O. Mental and behavioural outcome of infantile epilepsy treated by vigabatrin in tuberous sclerosis patients. Epilepsy Res 2000 ; 38 : 151-60.

72. Zamponi N, Cardinali C. Open comparative long-term study of vigabatrin vs carbamazepine in newly diagnosed partial seizures in children. Arch Neurol 1999 ; 56 : 605-7.

73. Ferrie CD, Robinson RO, Panayiotopoulos CP. Psychotic and severe behavioural reactions with vigabatrin : a review. Acta Neurol Scand 1996 ; 93 : 1-8.